RG
Therapeutic Areas
Invivyd Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VYD222 (Invymab) | Prevention of COVID-19 | Phase 3 |
| Next-Generation COVID-19 mAb | COVID-19 | Preclinical/Discovery |
| Influenza mAb Programs | Influenza | Discovery/Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| VYD222 (Invymab) | Prevention of COVID-19 | Phase 3 |
| Next-Generation COVID-19 mAb | COVID-19 | Preclinical/Discovery |
| Influenza mAb Programs | Influenza | Discovery/Preclinical |